Issued Patents All Time
Showing 1–9 of 9 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11419851 | Oral formulations of pyrrolidine derivatives | Oliver POHL | 2022-08-23 |
| 11312683 | Pyrrolidine derivatives as oxytocin/vasopressin via receptors antagonists | — | 2022-04-26 |
| 10752583 | Crystalline (3Z,5S)-5-(hydroxymethyl)-1-[(2′-methyl-1,1′-biphenyl-4-yl)carbonyl]pyrrolidin-3-one O-methyloxime, and methods of using the same | — | 2020-08-25 |
| 10604482 | Pyrrolidine derivatives as oxytocin/vasopressin via receptors antagonists | — | 2020-03-31 |
| 10478420 | Oral formulations of pyrrolidine derivatives | Oliver POHL | 2019-11-19 |
| 10047048 | Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists | — | 2018-08-14 |
| 9962367 | Oral formulations of pyrrolidine derivatives | Oliver POHL | 2018-05-08 |
| 9718772 | Crystalline (3Z,5S)-5-(hydroxymethyl)-1-[(2′-methyl-1,1′-biphenyl-4-yl)carbonyl]pyrrolidin-3-one O-methyloxime, and methods of using the same | — | 2017-08-01 |
| 9670155 | Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists | — | 2017-06-06 |